ALEMTUZUMAB - EFFECTS, APPLICATION & RISKS - ACTIVE INGREDIENTS

Alemtuzumab



Editor'S Choice
Common whirlwind
Common whirlwind
The monoclonal antibody alemtuzumab binds to certain white blood cells (B and T lymphocytes) and causes them to be broken down. While alemtuzumab was previously approved for chronic lymphocytic leukemia (CLL), it is now mainly used for multiple